The Blechman Foundation is a non-profit charitable organization dedicated to funding cutting-edge Parkinson’s disease research The Blechman Foundation provides early stage funding to identify and develop effective neuroprotective drugs, with the goal of bringing them to market as soon as possible. Neuroprotective drugs hold the promise of delaying or stopping the progression of Parkinson’s disease in the brain, which would relieve the suffering of millions of people and could prevent future generations from experiencing the disease altogether.